Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer

Published:2024-06-14 Issue:30 Volume:43 Page:2325-2337
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Chen Bo,Xu Pengfei,Yang Joy C.^ORCID,Nip Christopher,Wang Leyi,Shen Yuqiu,Ning Shu,Shang Yufeng,Corey Eva^ORCID,Gao Allen C.^ORCID,Gestwicki Jason E.^ORCID,Wei Qiang^ORCID,Liu Liangren,Liu Chengfei^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Defense

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41388-024-03081-6.pdf

Reference51 articles.

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.

2. Saha A, Kolonin MG, DiGiovanni J. Obesity and prostate cancer - microenvironmental roles of adipose tissue. Nat Rev Urol. 2023;20:579–96.

3. Siegel DA, O’Neil ME, Richards TB, Dowling NF, Weir HK. Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity - United States, 2001-7. MMWR Morb Mortal Wkly Rep. 2020;69:1473–80.

4. Aparicio A, Logothetis CJ, Maity SN. Understanding the lethal variant of prostate cancer: power of examining extremes. Cancer Discov. 2011;1:466–8.

5. Sternberg CN, Fizazi K, Saad F, Shore ND, De Giorgi U, Penson DF, et al. Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer. N Engl J Med. 2020;382:2197–206.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP